Fund Holdings — Euclidean Capital LLC

Total Portfolio Value:
$795.85M
Total Bought:
$114.40M
Total Sold:
$90.50M
Net Transaction:
+$23.90M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)974,6411,146,979+172,338$509.81M$624.21M78.43%+$114.40M
Ishares TrMSCI INDIA ETF
MSCI INDIA ETF
2,425,1442,425,1440$125.11M$135.27M17.00%+$10.16M
Foghorn Therapeutics Inc.(FHTX)1,573,7611,573,7610$10.56M$9.05M1.14%-$1.51M
ORIC Pharmaceuticals, Inc.(ORIC)989,410989,4100$13.60M$7.00M0.88%-$6.61M
Alector Inc1,307,8581,307,8580$7.87M$5.94M0.75%-$1.94M
PMV Pharmaceuticals, Inc.(PMVP)2,627,6432,627,6430$4.47M$4.26M0.53%-$210.2K
23andme Holding CoCL A10,243,12210,243,1220$5.45M$4.01M0.50%-$1.44M
Tenaya Therapeutics, Inc.(TNYA)1,015,7051,015,7050$5.31M$3.15M0.40%-$2.16M
Rapt Therapeutics Inc657,899657,8990$5.91M$2.01M0.25%-$3.90M
Surrozen, Inc.(SRZN)87,69687,6960$1.38M$960.3K0.12%-$417.4K
Surrozen, Inc.W EXP 08 01 203(SRZN)170,833170,8330$5.2K$2.8K0.00%-$2.3K
Ngm Biopharmaceuticals Inc992,1680-992,168$1.58M$0—-$1.58M
SPDR Gold SharesGOLD SHS(GLD)432,2710-432,271$88.93M$0—-$88.93M
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q2 2024 | TickerTrail